Milkhaus Laboratory, Inc.
Records under this name other than patents Milkhaus Laboratory, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Milkhaus Laboratory, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,998,121 | Method of treatment of connective tissue disorders by administration of streptolysin O Term ended Term ended Jun 2, 2024 · USPTO record | Term ended | Term ended Jun 2, 2024 | USPTO record |
| US 7,196,058 | Method of treatment of conditions by administration of streptolysin O Term ended Term ended Jun 2, 2024 · USPTO record | Term ended | Term ended Jun 2, 2024 | USPTO record |
| US 7,629,312 | Method of treatment of tendonitis by administration of streptolysin O Lapsed on the fee record Ended Dec 8, 2021 · USPTO record | Lapsed on the fee record | Ended Dec 8, 2021 | USPTO record |
| US 6,294,171 | Methods for treating disease states comprising administration of low levels of antibodies Term ended Term ended Jan 31, 2021 · USPTO record | Term ended | Term ended Jan 31, 2021 | USPTO record |
| US 6,437,093 | Methods of treatment comprising administration of Substance P Term ended Term ended Nov 28, 2020 · USPTO record | Term ended | Term ended Nov 28, 2020 | USPTO record |
| US 6,187,309 | Method for treatment of symptoms of central nervous system disorders Term ended Term ended Feb 29, 2020 · USPTO record | Term ended | Term ended Feb 29, 2020 | USPTO record |
| US 6,436,401 | Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies Term ended Term ended Feb 29, 2020 · USPTO record | Term ended | Term ended Feb 29, 2020 | USPTO record |
| US 6,713,058 | Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies Term ended Ended no later than Feb 29, 2020 · USPTO record | Term ended | Ended no later than Feb 29, 2020 | USPTO record |
| US 6,100,244 | Method for treating respiratory distress by sublingual administration of DNA Term ended Term ended Nov 3, 2019 · USPTO record | Term ended | Term ended Nov 3, 2019 | USPTO record |
| US 7,101,847 | Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin Lapsed on the fee record Ended Sep 5, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 5, 2018 | USPTO record |